We report the design, synthesis, immunological evaluation, and conformational analysis of new saponin variants as promising vaccine adjuvants. These studies have provided expedient synthetic access to streamlined adjuvant-active saponins and yielded molecularlevel insights into saponin conformation that correlated with their in vivo adjuvant activities
QS21 is a natural saponin extracted with water from the bark of endemic trees of South America which...
We have synthesized a QS-17/18 analogue (7) and evaluated its adjuvant activity in the formulation w...
We report the first synthesis and immunological evaluation of a new glycoconjugate design based on s...
We report the design, synthesis, immunological evaluation, and conformational analysis of new sapon...
We report the design, synthesis, immunological evaluation, and conformational analysis of new saponi...
We report the design, synthesis, immunological evaluation, and conformational analysis of new saponi...
QS-21 is a potent immunostimulatory saponin that is currently under clinical investigation as an adj...
Adjuvants are materials added to vaccines to enhance the immunological response to an antigen. QS-21...
Adjuvants are key immunostimulatory components in vaccine formulations, which improve the immune res...
Immunological adjuvants such as the saponin natural product QS-21 help stimulate the immune response...
Adjuvants are key immunostimulatory components in vaccine formulations that improve the immune respo...
Vaccine adjuvants are key for optimal vaccine efficacy, increasing the immunogenicity of the antigen...
Three structurally defined QS-21-based immune adjuvant candidates (<b>2a</b>–<b>2c</b>) have been sy...
360 p.Thesis (Ph.D.)--University of Illinois at Urbana-Champaign, 2009.The clinical success of conju...
Three QS-21-based vaccine adjuvant candidates with a terminal-functionalized side chain incorporated...
QS21 is a natural saponin extracted with water from the bark of endemic trees of South America which...
We have synthesized a QS-17/18 analogue (7) and evaluated its adjuvant activity in the formulation w...
We report the first synthesis and immunological evaluation of a new glycoconjugate design based on s...
We report the design, synthesis, immunological evaluation, and conformational analysis of new sapon...
We report the design, synthesis, immunological evaluation, and conformational analysis of new saponi...
We report the design, synthesis, immunological evaluation, and conformational analysis of new saponi...
QS-21 is a potent immunostimulatory saponin that is currently under clinical investigation as an adj...
Adjuvants are materials added to vaccines to enhance the immunological response to an antigen. QS-21...
Adjuvants are key immunostimulatory components in vaccine formulations, which improve the immune res...
Immunological adjuvants such as the saponin natural product QS-21 help stimulate the immune response...
Adjuvants are key immunostimulatory components in vaccine formulations that improve the immune respo...
Vaccine adjuvants are key for optimal vaccine efficacy, increasing the immunogenicity of the antigen...
Three structurally defined QS-21-based immune adjuvant candidates (<b>2a</b>–<b>2c</b>) have been sy...
360 p.Thesis (Ph.D.)--University of Illinois at Urbana-Champaign, 2009.The clinical success of conju...
Three QS-21-based vaccine adjuvant candidates with a terminal-functionalized side chain incorporated...
QS21 is a natural saponin extracted with water from the bark of endemic trees of South America which...
We have synthesized a QS-17/18 analogue (7) and evaluated its adjuvant activity in the formulation w...
We report the first synthesis and immunological evaluation of a new glycoconjugate design based on s...